vs

Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and CarParts.com, Inc. (PRTS). Click either name above to swap in a different company.

CarParts.com, Inc. is the larger business by last-quarter revenue ($120.4M vs $77.6M, roughly 1.6× Bioceres Crop Solutions Corp.). Bioceres Crop Solutions Corp. runs the higher net margin — -9.6% vs -9.6%, a 0.0% gap on every dollar of revenue. On growth, CarParts.com, Inc. posted the faster year-over-year revenue change (-9.8% vs -16.8%). Over the past eight quarters, Bioceres Crop Solutions Corp.'s revenue compounded faster (-8.4% CAGR vs -8.6%).

Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.

Genuine Parts Company (GPC) is an American automotive and industrial parts distributor based in Atlanta, Georgia. Established by brothers Carlyle and Malcolm Fraser in 1928, the company has approximately 60,000 employees. In addition to the United States, GPC has operated in Australasia, Belgium, Canada, France, Germany, Mexico, the Netherlands, Poland, and the United Kingdom. GPC's subsidiaries include industrial parts distributor Motion as well as NAPA Auto Parts, which primarily sells part...

BIOX vs PRTS — Head-to-Head

Bigger by revenue
PRTS
PRTS
1.6× larger
PRTS
$120.4M
$77.6M
BIOX
Growing faster (revenue YoY)
PRTS
PRTS
+7.0% gap
PRTS
-9.8%
-16.8%
BIOX
Higher net margin
BIOX
BIOX
0.0% more per $
BIOX
-9.6%
-9.6%
PRTS
Faster 2-yr revenue CAGR
BIOX
BIOX
Annualised
BIOX
-8.4%
-8.6%
PRTS

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BIOX
BIOX
PRTS
PRTS
Revenue
$77.6M
$120.4M
Net Profit
$-7.4M
$-11.6M
Gross Margin
46.8%
33.2%
Operating Margin
9.3%
Net Margin
-9.6%
-9.6%
Revenue YoY
-16.8%
-9.8%
Net Profit YoY
-20.2%
25.0%
EPS (diluted)
$-0.12
$-0.82

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BIOX
BIOX
PRTS
PRTS
Q4 25
$120.4M
Q3 25
$77.6M
$127.8M
Q2 25
$151.9M
Q1 25
$60.6M
$147.4M
Q4 24
$98.8M
$133.5M
Q3 24
$93.3M
$144.8M
Q2 24
$144.3M
Q1 24
$84.0M
Net Profit
BIOX
BIOX
PRTS
PRTS
Q4 25
$-11.6M
Q3 25
$-7.4M
$-10.9M
Q2 25
$-12.7M
Q1 25
$-1.6M
$-15.3M
Q4 24
$605.2K
$-15.4M
Q3 24
$-6.2M
$-10.0M
Q2 24
$-8.7M
Q1 24
$9.8M
Gross Margin
BIOX
BIOX
PRTS
PRTS
Q4 25
33.2%
Q3 25
46.8%
33.1%
Q2 25
32.8%
Q1 25
39.4%
32.1%
Q4 24
42.0%
32.5%
Q3 24
40.2%
35.2%
Q2 24
33.5%
Q1 24
50.8%
Operating Margin
BIOX
BIOX
PRTS
PRTS
Q4 25
Q3 25
9.3%
-7.9%
Q2 25
-8.2%
Q1 25
1.5%
-10.3%
Q4 24
14.5%
-11.6%
Q3 24
2.5%
-6.9%
Q2 24
-6.0%
Q1 24
15.7%
Net Margin
BIOX
BIOX
PRTS
PRTS
Q4 25
-9.6%
Q3 25
-9.6%
-8.5%
Q2 25
-8.4%
Q1 25
-2.6%
-10.4%
Q4 24
0.6%
-11.5%
Q3 24
-6.6%
-6.9%
Q2 24
-6.0%
Q1 24
11.6%
EPS (diluted)
BIOX
BIOX
PRTS
PRTS
Q4 25
$-0.82
Q3 25
$-0.12
$-0.19
Q2 25
$-0.23
Q1 25
$-0.02
$-0.27
Q4 24
$0.00
$-0.28
Q3 24
$-0.10
$-0.17
Q2 24
$-0.15
Q1 24
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BIOX
BIOX
PRTS
PRTS
Cash + ST InvestmentsLiquidity on hand
$15.5M
$25.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$288.3M
$53.5M
Total Assets
$734.9M
$184.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BIOX
BIOX
PRTS
PRTS
Q4 25
$25.8M
Q3 25
$15.5M
Q2 25
Q1 25
$38.5M
Q4 24
$29.2M
Q3 24
$32.3M
Q2 24
Q1 24
$16.4M
Stockholders' Equity
BIOX
BIOX
PRTS
PRTS
Q4 25
$53.5M
Q3 25
$288.3M
$64.2M
Q2 25
$62.4M
Q1 25
$345.0M
$72.8M
Q4 24
$346.3M
$85.2M
Q3 24
$346.0M
$97.2M
Q2 24
$103.9M
Q1 24
$348.5M
Total Assets
BIOX
BIOX
PRTS
PRTS
Q4 25
$184.9M
Q3 25
$734.9M
$200.3M
Q2 25
$189.6M
Q1 25
$798.2M
$216.5M
Q4 24
$835.2M
$210.6M
Q3 24
$827.3M
$227.6M
Q2 24
$238.0M
Q1 24
$836.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BIOX
BIOX
PRTS
PRTS
Operating Cash FlowLast quarter
$14.4M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BIOX
BIOX
PRTS
PRTS
Q4 25
Q3 25
$14.4M
$-6.4M
Q2 25
$-25.6M
Q1 25
$23.3M
$5.5M
Q4 24
$-5.4M
$1.8M
Q3 24
$5.2M
$8.5M
Q2 24
$-3.6M
Q1 24
$-17.4M
Free Cash Flow
BIOX
BIOX
PRTS
PRTS
Q4 25
Q3 25
$-8.3M
Q2 25
$-27.9M
Q1 25
$3.4M
Q4 24
$-631.0K
Q3 24
$4.9M
Q2 24
$-10.8M
Q1 24
FCF Margin
BIOX
BIOX
PRTS
PRTS
Q4 25
Q3 25
-6.5%
Q2 25
-18.3%
Q1 25
2.3%
Q4 24
-0.5%
Q3 24
3.4%
Q2 24
-7.5%
Q1 24
Capex Intensity
BIOX
BIOX
PRTS
PRTS
Q4 25
Q3 25
1.5%
Q2 25
1.5%
Q1 25
1.4%
Q4 24
1.8%
Q3 24
2.5%
Q2 24
4.9%
Q1 24
Cash Conversion
BIOX
BIOX
PRTS
PRTS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-8.85×
Q3 24
Q2 24
Q1 24
-1.78×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons